Whether you’re in drug development, market access, or health economics, early scientific advice plays a critical role in de-risking clinical development, accelerating timelines, and strengthening pricing strategy.
In this on-demand webinar, Remap experts Graham Foxon and Charlie Hewitt share practical tools and real-world insights on how to secure high-quality early feedback from HTA bodies, and introduce the BRAVE framework, Remap’s proven approach to successful engagement.
Key Points Covered:
- Why early payer input is key to pricing and access success
- The BRAVE framework: a step-by-step approach to getting the right feedback
- How to approach HTA bodies like NICE, G-BA, and EU JSC
- Real-world examples of successful scientific advice strategies
- Tips for aligning internal teams and defining strategic objectives
Access the webinar by clicking the below image or HERE:
If you have any questions or would like to discuss the topic in more detail, please reach out.
Want to dive deeper? Check out these related articles for more insights: